Navigation Links
Resonetics Growth Leads to New Facility
Date:1/3/2011

NASHVILLE, Tenn., Jan. 3, 2011 /PRNewswire/ -- Resonetics LLC is proud to announce that during the spring of 2011, the company will be relocated from its current Nashua, New Hampshire facility to a significantly larger facility a short distance away and still remain in the Nashua area.  The new facility has a footprint that is 50% larger than the current footprint with a significant portion allocated to medical device component and service manufacturing.  The company also plans to double again by 2012 and has reserved surrounding space to ensure expansion.

According to Cliff Gabay, President of Resonetics, "It is especially rewarding to our employees that Resonetics is experiencing significant growth opportunities in the medical device market.  Over the last few years, our company has executed the strategic plan to focus on medical device components and system business as well as exploding opportunities in diabetes and diagnostics, to name a few.  The net result is that we are overflowing in our current facility and we look forward to the new facility to continue executing our exciting growth plans."

The company chose to remain in the Nashua, NH area because it would be less disruptive to the employees who played a critical role to the success of the company. "Our core technology is laser micromachining and we leverage our success partly on the talents of our technical staff who have created intellectual property that has put us in this enviable position."

About Resonetics LLC:

Resonetics is the largest total solution provider of laser micromachining products and services in the world. It is also regarded as having the largest independent plastic (polymer) laser micromachining facility with more than 50 UV‐based laser micromachining systems and with three clean rooms. Laser micromachining represents a critical fabrication technology for the manufacturing of medical devices, diagnostics, and a variety of non‐medical products as the machining features become increasingly small.

The US‐based company has three separate business divisions: The Medical Division, The Laser Micromachining Division (for Contract Manufacturing Services) and The Laser Systems Division (for capital equipment).


'/>"/>
SOURCE Resonetics LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
2. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
3. Bionovo to Present at Canaccord Adams Global Growth Conference
4. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
5. KJT Group Positions for Substantial Growth
6. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
7. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
8. Filter Markets - Discover the Growth Segments
9. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts
10. Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
11. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
(Date:3/22/2017)... TORONTO , March 22, 2017 /PRNewswire/ - ... Therapeutics (the "Company" or "Propellon"), a start-up created ... WDR5-targeted anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive ... lead program. The seed funding enables Propellon to ... position the Company for financing and/or entering a ...
(Date:3/22/2017)... ... 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL will be the ... “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” As the Bahamas’ ... and Therapy Act, Okyanos maintains a mission to help “no-option” patients and those ...
Breaking Biology Technology:
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant kiosk ... At PTE 2017 ... Materna will present its complete end-to-end passenger journey, from ... benefit for passengers. To accelerate the whole passenger handling process, ... to take passengers through the complete integrated process with a ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):